Skip to main content
. 2017 Jun 23;96(25):e7213. doi: 10.1097/MD.0000000000007213

Table 2.

Hazard ratios of hospitalization for cardiovascular disease in patients treated with DPP-4 inhibitors versus glimepiride.

3.2.